Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Commercially available AMPs are still a long way off, but research on their structure and antimicrobial activity is ... lyp1987’s antibacterial activity against both Gram-positive and Gram-negative ...

To overcome this limitation, the research team introduced a macromolecular quaternary ammonium salt (QPEI) to the DBM structure ... including Gram-positive and Gram-negative strains, such as ...